VIADERM, LLC

Basic Information

3550 W. Liberty, Suite 3
ANN ARBOR, MI, 48103-8802

Company Profile

n/a

Additional Details

Field Value
DUNS: 78309332
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. Novel, Long-Term Percutaneous Access Device for Chronic Therapy

    Amount: $1,455,890.00

    DESCRIPTION: A novel, next-generation percutaneous access device (PAD) focused on pre-emptively reducing catheter related exit site infection will be developed for the delivery of chronic, life-sust ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. NOVEL, LONG-TERM PERCUTANEOUS ACCESS DEVICE FOR CHRONIC THERAPY

    Amount: $308,409.00

    DESCRIPTION (provided by applicant): A novel, next-generation percutaneous access device (PAD) will be developed for the delivery of chronic and life-sustaining therapies requiring long-term access th ...

    SBIR Phase I 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government